← Issue №1/ week of Jun 24, 2026/Colorectal

Competing Mortality Redefines the Net Benefit of Additional Surgery After Endoscopic Resection for T1 Colorectal Cancer in Older Adults.

From GI Signals issue №1: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Colorectal prospective cohort · Jul 1, 2026 · Dig Endosc · IF 5.2

Competing Mortality Redefines the Net Benefit of Additional Surgery After Endoscopic Resection for T1 Colorectal Cancer in Older Adults.

New evidence
Clinical takeawayFor older adults (≥80y) with high-risk T1 CRC, weigh delayed oncologic benefit (10+ years) against immediate surgical risks; consider pathologic risk, frailty, comorbidity, and competing mortality. Avoid routine additional surgery in frail or comorbid patients.
What it foundMeta-analysis shows the survival advantage of additional surgery for T1 CRC in older adults (≥80y) only becomes evident after 10 years, while perioperative morbidity occurs immediately.
ContextRefines prior standard of recommending additional surgery for all high-risk T1 CRC by showing age-specific trade-offs in competing mortality.
Refinessuggested applicable standard· U.S. Multi-Society Task Force on Colorectal Cancer (Rex DK, Boland CR, Dominitz JA, et al.), "Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer," Gastroenterology, 2017

Decision at stakewhether to recommend additional surgery after endoscopic resection for T1 colorectal cancer in older adults

Begin average-risk colorectal cancer screening at age 45 using a patient-centered shared-decision modality choice, colonoscopy every 10 years (preferred) or annual FIT as Tier 1 options, with multi-target stool DNA every 3 years, CT colonography every 5 years, or flexible sigmoidoscopy every 5 to 10 years as Tier 2 alternatives. A positive stool-based test requires diagnostic colonoscopy, and stool tests should not be ordered for patients who would decline follow-up colonoscopy. Generally stop at age 75 with individualized decisions for ages 76-85 and no screening beyond 85.

U.S. Multi-Society Task Force on Colorectal Cancer (Rex DK, Boland CR, Dominitz JA, et al.), "Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer," Gastroenterology, 2017 · reviewed 2026-07-23 ↗
Ichimasa K … Misawa M · Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society · IF 5.2 · PubMed ↗Permalink
← Read the whole of issue №1 Every paper GI Signals surfaces gets a page like this one. All issues